Table 1.
Case | Age | Sex | Clinical T stage | Grade | SLN | LN (mets) |
---|---|---|---|---|---|---|
1 | 63 | Male | T4 | 3 | + | 7 |
2 | 65 | Male | Tis | 2>3 | + | 6 |
3 | 74 | Male | T1 | 2>3 | + | 10 |
4 | 77 | Male | T4 | 3 | - | 20 (3) |
5 | 66 | Male | Tis | 3 | - | 27 (6) |
6 | 68 | Male | T3 | 3>2 | + | 13 |
7 | 71 | Male | T1 | 2>3 | + | 13 |
8 | 77 | Male | T3 | 3 | - | 21 (12) |
9 | 73 | Male | T3 | 3>2 | - | 20 (17) |
10 | 73 | Female | T3 | 3 | + | 14 |
11 | 73 | Male | T3 | 3 | - | 19 (5) |
12 | 62 | Male | T1 | 2>3 | + | 19 |
Tis: carcinoma in situ; SLN: sentinel lymph node; LN: lymph node.